Skip to main content
. 2020 Mar 11;17(6):1818. doi: 10.3390/ijerph17061818

Table 3.

Comparison of the blood biochemical parameters between the participants with and without MAFLD.

Blood Parameters MAFLD Control t p Value
WBC, ×109/L 6.30 ± 1.63 5.82 ± 1.57 13.0958 <0.001
RBC, ×1012/L 4.86 ± 0.47 4.72 ± 0.46 13.1568 <0.001
HGB, g/L 142.54 ± 15.93 138.17 ± 16.72 11.5679 <0.001
PLT, ×109/L 247.11 ± 63.43 238.42 ± 63.68 5.9598 <0.001
NEUT%, % 58.26 ± 8.09 58.49 ± 8.59 −1.1907 0.234
LYMPH%, % 33.88 ± 7.59 33.56 ± 7.99 1.8054 0.071
MONO%, % 5.43 ± 1.32 5.56 ± 1.44 −4.2614 <0.001
EO%, % 2.01 ± 1.70 1.97 ± 1.93 1.0541 0.292
BASO%, % 0.42 ± 0.30 0.42 ± 0.33 −0.0335 0.973
ALT, U/L 24.90 ± 17.89 20.38 ± 20.96 9.8647 <0.001
AST, U/L 23.38 ± 8.55 22.97 ± 11.85 1.6300 0.103
ALP, U/L 87.37 ± 24.71 86.01 ± 26.01 2.3148 0.021
TBIL, μmol/L 16.64 ± 7.33 16.35 ± 7.58 1.7072 0.088
Urea, mmol/L 5.10 ± 1.38 5.03 ± 1.45 2.3892 0.017
CR, μmol/L 62.73 ± 13.60 61.71 ± 14.13 3.1972 0.001
TG, mmol/L 2.10 ± 1.58 1.46 ± 1.08 22.3593 <0.001
TC, mmol/L 5.38 ± 1.05 5.17 ± 1.03 8.9123 <0.001
HDL-C, mmol/L 1.17 ± 0.27 1.33 ± 0.31 −23.7332 <0.001
LDL-C, mmol/L 3.09 ± 0.85 2.93 ± 0.85 8.5616 <0.001
SUA, μmol/L 314.05 ± 86.62 277.21 ± 76.86 20.0556 <0.001
FPG, mmol/L 6.12 ± 1.82 5.63 ± 1.42 13.5223 <0.001
HBA1c, % 5.96 ± 1.10 5.64 ± 0.89 14.6705 <0.001

MAFLD: Metabolic associated fatty liver disease; WBC: white blood cell; RBC: red blood cell; HGB: hemoglobin; PLT: platelets; NEUT%: percentage of neutrophils; LYMPH%: percentage of lymphocytes; MONO%: percentage of monocytes; EO%: percentage of eosinophils; BASO%: percentage of basophils; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; TBIL: total bilirubin; CR: creatinine; TG: triglyceride; TC: serum total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SUA: serum uric acid; FPG: fasting plasma glucose; HBA1c: hemoglobin A1c.